New study tests clotting drug for safer surgery in women with hemophilia a

NCT ID NCT05936580

Recruiting now Disease control Sponsor: Octapharma Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a drug called Nuwiq, a lab-made clotting factor, to prevent excessive bleeding during major surgery in women and girls with hemophilia A. About 28 participants will receive Nuwiq around the time of their surgery. Researchers will check if the drug successfully controls bleeding during and after the operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nuwiq (a lab-made clotting factor VIII)
What this could lead to: If successful, this could confirm that Nuwiq is a safe and effective option to control bleeding during surgery for women and girls with hemophilia A.
What could go wrong: This is a small, single-group study with only 28 participants, so results may not apply to everyone. As a phase 4 trial, it is confirmatory, but unexpected side effects or lack of efficacy are still possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemophilia A

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMOPHILIA A

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Avenue de la République
RECRUITING

Chambray-lès-Tours, France
Aziendo Ospedaliera "Puglieze Ciaccio"
RECRUITING

Catanzaro, Italy
CHU de Nantes Hôtel-Dieu
RECRUITING

Nantes, France
Centro Hospitalario Pereira Rossell
NOT_YET_RECRUITING

Montevideo, Uruguay
Chu de Strasbourg
NOT_YET_RECRUITING

Stasbourg, France
Clinical Center for Serbia
RECRUITING

Belgrade, Serbia
Gerinnungszentrum Rhein-Ruhr
RECRUITING

Duisburg, Germany
Helsinki University Hospital,Coagulation Disorder Unit
RECRUITING

Helsinki, Finland
Hospital Universitario Virgen del Rocio
RECRUITING

Seville, Spain
Hospital Universitario la Paz
RECRUITING

Madrid, Spain
Insel Spital Bern
NOT_YET_RECRUITING

Bern, Switzerland
Policlinico "P. Giaconne"
RECRUITING

Palermo, Italy
St. James's University Hospital
RECRUITING

Leeds, United Kingdom
UT Health San Antonio
RECRUITING

San Antonio, Texas, 78229, United States
Universitätsklinikum Bonn,Institut für Experimentelle Haematologie und Transfusionsmedizin
RECRUITING

Bonn, Germany
Universitätsklinikum Hamburg Eppendorf,II. Medizinische Klinik und Poliklinik
RECRUITING

Hamburg, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.